$9.50—
NASDAQ
$9.50—
KDMN Stock: Why It Surged Today
Kadmon Stock Soars as Sanofi Buys U.S. Biotech for $1.9 Billion
Sanofi's $1.9 Billion Bet On Kadmon: What You Need to Know
KDMN Stock: Over 75% Stock Increase Pre-Market Explanation
Sanofi to acquire U.S. biopharmaceutical group Kadmon in $1.9 billion deal
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 billion deal
5 Penny Stocks Analysts Say To Buy With Targets Up To 300%
7 Penny Stocks To Buy According To Analysts With Targets Up To 316%
Kadmon's REZUROCK Scores Quick FDA Win For Chronic Graft-Versus-Host Disease
Kadmon's graft-versus-host treatment gets FDA approval